Global News and Digital Insights
for the Healthcare Industry

Day: April 29, 2022

Bristol Myers’ oral heart disease drug bags FDA’s approval

HealthGeniuses April 29, 2022

Bristol Myers Squibb’s Mavacamten, an oral drug, becomes the first cardiac myosin inhibitor that has been approved by the US Food and Drug Administration (FDA). Patients, specifically adults, with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (HCM) are eligible to be treated by the said drug. Bristols Myers gained Mavacamten from MyoKardia back in 2020 on a buyout at a price of $13 billion. The firm claims Mavacamten will improve functionality and treat symptoms. Read More from Reuters

Researchers from Boston Children Hospital and Yonsei University created AI model to predict no-shows

HealthGeniuses April 29, 2022

Researchers from Boston Children’s Hospital and Yonsei University created an AI Model-a machine learning tool- to predict no-shows at appointments in the paediatric department with the help of weather forecast information. While looking at several factors with the help of the data imputation method, no-show appointments can be anticipated. The data imputation is adopted to check insufficient patients’ information and local weather information as they are indicative of whether a patient will show up at the appointment or not. This model is devised to combat the problems that arise from no-shows in terms of hospitals’ and clinics’ resources and patients’ health. Read More from HealthcareITNews

UCM and Empress EMS team up to provide virtual and hands-on medical care to limit in person visits

HealthGeniuses April 29, 2022

UCM Digital Health, a firm that provides telehealth facilities of triage and support to patients, has entered into a partnership with Empress Emergency Medical Services (EMS). This alliance aims to form a virtual integrated mobile network that can address the concerns of patients wherever and whenever they require it. Although the major objective of this partnership is to limit unnecessary hospital visits, as an extension of UMC, Empress will enable patients to get hands-on care services if they need. After a virtual consultation, if UMC deems it necessary for the patient to get physical care, Empress will deploy their paramedics to the site where patient resides. This innovation will make it easier for patients to communicate with their doctors. Read More from HealthDive

FDA approves AstraZeneca’s Ultomiris for the 3rd time

HealthGeniuses April 29, 2022

AstraZeneca’s Ultomiris has been approved by the FDA for the treatment of neurological disorders in the past. However, it has once again been acclaimed for the treatment of myasthenia gravis (gMG), a neuromuscular disorder that affects muscle functioning and causes extreme weakness. Initially, Ultomiris was approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. Experts believe that Ultomiris can be expected to give a tough time to Soliris as it costs less and has to be infused every eight weeks, contrary to Soliris which has to be infused every two weeks. Read More from FiercePharma 

SSM Health and Saint Louise University furthering their partnership to present an integrated healthcare delivery network

HealthGeniuses April 29, 2022

Saint Louise University and SSM Health are the two largest and most esteemed catholic firms in the region. With their decade-long partnership, they are further entering into the agreement of nurturing their collaboration to promote health equity, improve education, and look after St. Louise’s community. SLUCare has agreed to leverage their world-class medical expertise relating to academia, while SSM Health’s will align it with their community-based care model to come up with an integrated network. SSM Health will receive ownership once the transaction is completed. The network will assist people in accessing every level of required healthcare from primary care to specialised life-saving treatments. Read More from SLUEdu 

Dubai to become the first in UAE to build a robotic biobank

HealthGeniuses April 29, 2022

Al Jalila Foundation in collaboration with Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Dubai Health Authority (DHA) is soon to build the first robotic biobank that will be used as a platform for medical research. The said charity organisation is a member of Mohammed Bin Rashid Al Maktoum Global Initiatives which, through the help of biobank, intends to carry out discoveries and research that are related to chronic diseases, such as cancer, and pandemics. In 2023, this robotic biobank will become the world’s largest with respect to its sample capacity. Read More from GulfNews

Bristol Myers’ oral heart disease drug bags FDA’s approval

HealthGeniuses April 29, 2022

Bristol Myers Squibb’s Mavacamten, an oral drug, becomes the first cardiac myosin inhibitor that has been approved by the US Food and Drug Administration (FDA). Patients, specifically adults, with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (HCM) are eligible to be treated by the said drug. Bristols Myers gained Mavacamten from MyoKardia back in 2020 on a buyout at a price of $13 billion. The firm claims Mavacamten will improve functionality and treat symptoms. Read More from Reuters

Researchers from Boston Children Hospital and Yonsei University created AI model to predict no-shows

HealthGeniuses April 29, 2022

Researchers from Boston Children’s Hospital and Yonsei University created an AI Model-a machine learning tool- to predict no-shows at appointments in the paediatric department with the help of weather forecast information. While looking at several factors with the help of the data imputation method, no-show appointments can be anticipated. The data imputation is adopted to check insufficient patients’ information and local weather information as they are indicative of whether a patient will show up at the appointment or not. This model is devised to combat the problems that arise from no-shows in terms of hospitals’ and clinics’ resources and patients’ health. Read More from HealthcareITNews

UCM and Empress EMS team up to provide virtual and hands-on medical care to limit in person visits

HealthGeniuses April 29, 2022

UCM Digital Health, a firm that provides telehealth facilities of triage and support to patients, has entered into a partnership with Empress Emergency Medical Services (EMS). This alliance aims to form a virtual integrated mobile network that can address the concerns of patients wherever and whenever they require it. Although the major objective of this partnership is to limit unnecessary hospital visits, as an extension of UMC, Empress will enable patients to get hands-on care services if they need. After a virtual consultation, if UMC deems it necessary for the patient to get physical care, Empress will deploy their paramedics to the site where patient resides. This innovation will make it easier for patients to communicate with their doctors. Read More from HealthDive

FDA approves AstraZeneca’s Ultomiris for the 3rd time

HealthGeniuses April 29, 2022

AstraZeneca’s Ultomiris has been approved by the FDA for the treatment of neurological disorders in the past. However, it has once again been acclaimed for the treatment of myasthenia gravis (gMG), a neuromuscular disorder that affects muscle functioning and causes extreme weakness. Initially, Ultomiris was approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. Experts believe that Ultomiris can be expected to give a tough time to Soliris as it costs less and has to be infused every eight weeks, contrary to Soliris which has to be infused every two weeks. Read More from FiercePharma 

SSM Health and Saint Louise University furthering their partnership to present an integrated healthcare delivery network

HealthGeniuses April 29, 2022

Saint Louise University and SSM Health are the two largest and most esteemed catholic firms in the region. With their decade-long partnership, they are further entering into the agreement of nurturing their collaboration to promote health equity, improve education, and look after St. Louise’s community. SLUCare has agreed to leverage their world-class medical expertise relating to academia, while SSM Health’s will align it with their community-based care model to come up with an integrated network. SSM Health will receive ownership once the transaction is completed. The network will assist people in accessing every level of required healthcare from primary care to specialised life-saving treatments. Read More from SLUEdu 

Dubai to become the first in UAE to build a robotic biobank

HealthGeniuses April 29, 2022

Al Jalila Foundation in collaboration with Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Dubai Health Authority (DHA) is soon to build the first robotic biobank that will be used as a platform for medical research. The said charity organisation is a member of Mohammed Bin Rashid Al Maktoum Global Initiatives which, through the help of biobank, intends to carry out discoveries and research that are related to chronic diseases, such as cancer, and pandemics. In 2023, this robotic biobank will become the world’s largest with respect to its sample capacity. Read More from GulfNews

HealthGeniuses

Curated News and Digital
Insights for the Healthcare Industry

IndustryGeniuses
GroceryGeniuses
ConsumerGeniuses
MetaGeniuses
FashionGeniuses

HealthGeniuses

According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.

Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.

HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.

IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.

© 2024 IndustryGeniuses Ltd. All Rights Reserved.